OQROGet OQRO Pro
Insider trade

Clarivate (CLVT)Director bought ~$1.21M

Kenneth L. Cornick, Director at Clarivate, bought ~$1.21M of Clarivate shares.

~$1.21M
Approx. value · 650K sh @ $1.86
1.75M
Holds after · shares reported
Traded
Aug 6, 2026
Filed
Aug 11, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 31, 2025Federal contract · $5.9M obligatedDepartment of the Treasury awarded CLARIVATE PLC: $5.93M obligated to date
  2. Jan 28, 2026Federal contract · $1.3M obligatedDepartment of Commerce awarded CLARIVATE PLC: $1.29M obligated to date
  3. Mar 31, 2026Federal contract · $2.4M obligatedDepartment of Homeland Security awarded CLARIVATE PLC: $2.4M obligated to date
  4. Apr 1, 2026Federal contract · $9.2M obligatedDepartment of Justice awarded CLARIVATE PLC: $9.17M obligated to date
  5. Apr 2, 2026Federal contract · $5.4M obligatedDepartment of Homeland Security awarded CLARIVATE PLC: $5.44M obligated to date
  6. Apr 6, 2026Federal contract · $696K obligatedDepartment of Agriculture awarded CLARIVATE PLC: $696K obligated to date
  7. May 29, 2026Federal contract · $3.0M obligatedDepartment of Health and Human Services awarded CLARIVATE PLC: $3.01M obligated to date
  8. Jun 5, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“Maroun S. Mourad, President, Intellectual Property of Clarivate Plc (the “Company”) will depart from his position, effective June 9, 2026. Following such date, Mr. Mourad will remain employed by the Company in a non-executive advisory role until September 30, 2026.”
  9. Jul 3, 2026Company filing · Form 8-K · Material agreement, Executive changeChanged a top executive or board member, and signed an important agreement“On July 3, 2026, a subsidiary of Clarivate entered into a retention agreement with Henry Levy, Clarivate’s President, Life Sciences & Healthcare, to encourage his continued commitment toward the completion of the Transaction.”
  10. Jul 24, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On July 24, 2026, Jonathan Collins, the Executive Vice President & Chief Financial Officer of Clarivate Plc (the “Company”) resigned from his position, effective August 7, 2026.”
  11. Jul 29, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  12. Aug 3, 2026Insider · 1 personInsiders: 3 sales (~$4.8M)
  13. Aug 6, 2026 · this disclosureInsiderDirector purchased ~$1.21M of CLVT shares in the open market

What came next

  1. Aug 7, 2026InsiderDirector purchased ~$463K of CLVT shares in the open market
  2. Sep 25, 2026Federal contract · $988K obligatedFederal Trade Commission awarded CLARIVATE PLC: $988K obligated to date
  3. Oct 6, 2026Company filing · Form 8-K · Acquisition or sale, Executive changeCompleted buying or selling a business or assets, and changed a top executive or board member (and 1 more item)“Upon the Closing and in connection with the Transaction, Henry Levy, Clarivate’s President, Life Sciences & Healthcare, terminated employment with a subsidiary of Clarivate.”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Clarivate

For Clarivate, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CLVT page.

Other recent filings by Kenneth L. Cornick, Director

The full history of Kenneth L. Cornick, Director is on the profile page.

How this filing works

Other disclosures at Clarivate

Everything OQRO holds on this company is on its CLVT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data